Louisiana 2015 2015 Regular Session

Louisiana House Bill HB210 Comm Sub / Analysis

                    Moreno	HB No. 210
(KEYWORD, SUMMARY, AND DIGEST as amended by Senate committee
amendments)
DRUGS  Authorizes the prescribing or dispensing of naloxone to third parties
DIGEST
Proposed law authorizes a licensed medical practitioner to, directly or by standing order,
prescribe or dispense the drug naloxone or another opioid antagonist without having
examined the individual to whom it may be administered if both of the following conditions
are met:
(1)The licensed medical practitioner provides the individual receiving and administering
the naloxone or other opioid antagonist all training required by the Dept. of Health
and Hospitals (DHH) for the safe and proper administration of naloxone or another
opioid antagonist to individuals who are undergoing or who are believed to be
undergoing an opioid-related drug overdose.  The training, at a minimum, shall
address all of the following:
(a)Techniques on how to recognize signs of an opioid-related overdose.
(b)Standards and procedures for the storage and administration of naloxone or
another opioid antagonist.
(c)Emergency follow-up procedures including the requirement to summon
emergency services either immediately before or immediately after
administering the naloxone or other opioid antagonist to an individual
apparently experiencing an opioid-related overdose.
(2)The naloxone or other opioid antagonist is prescribed or dispensed in such a manner
that it shall be administered through a device approved for this purpose by the U. S.
Food and Drug Administration.
Proposed law requires a licensed pharmacist to dispense naloxone or another opioid
antagonist prescribed, directly or by standing order, by a licensed medical practitioner
pursuant to proposed law.
Proposed law limits civil, criminal, and professional liability for a licensed medical
practitioner who, in good faith, prescribes or dispenses or a pharmacist who, in good faith,
dispenses naloxone or another opioid antagonist pursuant to proposed law.
Proposed law limits civil and criminal liability for a person acting in good faith who receives
and administers naloxone or another opioid antagonist to a person reasonably believed to be
undergoing an opioid-related drug overdose unless personal injury results from the gross
negligence or willful or wanton misconduct in the administration of the drug.
Proposed law requires DHH to develop and promulgate a set of best practices for use by a
licensed medical practitioner including but not limited to the training necessary to safely and
properly administer naloxone or another opioid antagonist to individuals who are undergoing
or who are believed to be undergoing an opioid-related drug overdose, the standards and
procedures for the storage and administration of naloxone or another opioid antagonist, and
emergency follow-up procedures.
Proposed law provides definitions.
(Adds R.S. 40:978.2)
Page 1 of 2
Prepared by Christopher D. Adams. Summary of Amendments Adopted by House
The Committee Amendments Proposed by House Committee on Health and Welfare to
the original bill:
1. Make a technical change.
The House Floor Amendments to the engrossed bill:
1. Clarify that the prescriber must provide training to the individual who will
administer the naloxone or other opioid antagonist.
Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Health and Welfare to the
reengrossed bill
1. Removes the provision that the naloxone or another opioid antagonist be
administered by a device approved by the FDA for the intranasal administration
of liquid drug.
Page 2 of 2
Prepared by Christopher D. Adams.